Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAYER HEALTHCARE

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 31
  • 0 comments

FDA approve DAROLUTAMIDE

Comment Full text

AZURITY

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 34
  • 0 comments

FDA approve MELOXICAM

Comment Full text

NOVARTIS

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 33
  • 0 comments

FDA approve ELTROMBOPAG OLAMINE

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 30
  • 0 comments

FDA approve PEMBROLIZUMAB

Comment Full text

EMD SERONO INC

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 30
  • 0 comments

FDA approve AVELUMAB

Comment Full text

SANDOZ

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 25
  • 0 comments

FDA approve ONDANSETRON HYDROCHLORIDE

Comment Full text

RUBICON RESEARCH

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 27
  • 0 comments

FDA approve FLUTICASONE PROPIONATE

Comment Full text

RTU PHARMA SA

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 32
  • 0 comments

FDA approve TRANEXAMIC ACID

Comment Full text

CIPHER PHARMS INC

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 33
  • 0 comments

FDA approve FENOFIBRATE

Comment Full text

GLAND

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 24
  • 0 comments

FDA approve EPINEPHRINE

Comment Full text
  • Previous
  • 102
  • 103
  • 104
  • 105
  • 106
  • Next

Search

News categories

  • Technical Exchange News(10326)
  • Event(1496)
  • SEC News(175944)
  • FDA Approval(9659)
  • Company Report(721)
  • Business News(117973)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin